|
The practice of medicine is changing almost daily. Strategies that hasten adherence to guidelines and optimize patient care are being developed and utilized. Appropriate therapy to reduce atherothrombotic risk...
Faculty
|
Activity Details
- Credit Types:
CME
- Credit Amount: 0.50
-
Type: Podcast
- Expires: Oct 10, 2009
- Cost: Free
|
|
CVD affects approximately 80 million Americans and is responsible for roughly one third of US mortality, with nearly 2400 CVD-associated deaths occurring each day—more than cancer, chronic lower respiratory...
Faculty
|
Activity Details
- Credit Types:
CME, CPE
- Credit Amount: 1.00
-
Type: PDF
- Expires: Jul 1, 2009
- Cost: Free
|
|
Over 75 million US adults have cardiovascular disease (CVD), the leading cause of death in the United States. Of those individuals with CVD, approximately 17 million have coronary artery disease (CAD), leading to...
Faculty
|
Activity Details
- Credit Types:
CME, CPE
- Credit Amount: 1.00
-
Type: Audio Webcast
- Expires: Jun 4, 2009
- Cost: Free
|
|
Over 75 million US adults have cardiovascular disease (CVD), the leading cause of death in the United States. Of those individuals with CVD, approximately 17 million have coronary artery disease (CAD), leading to...
Faculty
|
Activity Details
- Credit Types:
CME, CPE
- Credit Amount: 1.00
-
Type: Audio Webcast
- Expires: Jun 2, 2009
- Cost: Free
|
|
This presentation aims to address the central role of platelets in acute coronary syndromes (ACS) and the use of both oral antiplatelet therapy and interventional therapy as cornerstones...
Faculty
|
Activity Details
- Credit Types:
CME
- Credit Amount: 0.50
-
Type: Video Webcast
- Expires: Feb 28, 2009
- Cost: Free
|
|
This presentation aims to focus on current strategies to optimize oral antiplatelet agents in the treatment of ACS and PCI. Topics addressed include current limitations with clopidogrel, variability in response...
Faculty
|
Activity Details
- Credit Types:
CME
- Credit Amount: 0.50
-
Type: Video Webcast
- Expires: Feb 28, 2009
- Cost: Free
|
|
This presentation focuses on the results of the TRITON-TIMI 38 trial, which examines the use of the investigational thienopyridine prasugrel compared to clopidogrel in patients with ACS who were undergoing...
Faculty
|
Activity Details
- Credit Types:
CME
- Credit Amount: 1.00
-
Type: Video Webcast
- Expires: Feb 28, 2009
- Cost: Free
|
|
Biologic agents that block TNF have proven highly effective in improving the signs and symptoms of rheumatoid arthritis (RA), preventing the progression of joint damage, and improving functional status and...
Faculty
|
Activity Details
- Credit Types:
CME, CPE, CNE
- Credit Amount: 0.50
-
Type: Video Webcast
- Expires: Feb 19, 2009
- Cost: Free
|
|
E-mail
Begin